Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 663

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 663
---
 or order by a Governmental Entity or by a third party against the Company or SPAC, as applicable, (each, a “

#### Conforming Schedule Update
”). Each Conforming Schedule Update will be deemed to amend and supplement the Company Disclosure Schedules or the SPAC Disclosure Schedules, as applicable, as of the Closing Date; provided, that no such Conforming Schedule Update shall limit or otherwise affect any Party’s rights or remedies available hereunder. Any Conforming Schedule Update shall be provided in accordance with the notice provisions hereof and shall be clearly labeled as a “Disclosure Schedule Update.”“

<div align='center'>A-74</div>

TABLE OF CONTENTS

3. Effect on Agreement . Except as set forth in this Amendment, all of the terms, covenants, agreements, and conditions of the Agreement shall remain in full force and effect in accordance with its original terms.

4. Governing Law . This Amendment shall be governed by and construed in accordance with the laws of the State of New York without regard to any conflicts of laws principles thereto that would call for the application of the laws of any other jurisdiction.

5. Counterparts, Facsimile Signatures . This Amendment may be executed in any number of identical counterparts, each of which, for all purposes, is to be deemed an original, and all of which constitute, collectively, one and the same Amendment. Signatures transmitted by electronic means such as email or facsimile shall have the same legal effect as an original signature hereto.

<div align='center'>[Signature page to follow.]

A-75</div>

TABLE OF CONTENTS

IN WITNESS WHEREOF, this Amendment has been duly executed and delivered by each of the Parties as of the date first above written.

#### SPAC
Iris Acquisition Corp

By:

/s/ Sumit Mehta

Name: Sumit Mehta 
 Title: Chief Executive Officer

### COMPANY
Liminatus Pharma, LLC

By:

/s/ Chris Kim

Name: Chris Kim 
 Title: CEO, Secretary and Treasurer

### PARENTCO
Iris Parent Holding Corp.

By:

/s/ Chris Kim

Name: Chris Kim 
 Title: CEO, Secretary and Treasurer

<div align='center'>Signature Page to Amendment to Business Combination Agreement

A-76</div>

TABLE OF CONTENTS

### SECOND AMENDMENT TO BUSINESS COMBINATION AGREEMENT
This Second Amendment to Business Combination Agreement (this “

#### Amendment
”) is entered into as of August 14